title: Preserved olfactory short-term memory after combined cholinergic and serotonergic lesions using 192 IgG-saporin and 5,7-dihydroxytryptamine in rats.
abstract: Young adult Long-Evans female rats were subjected to intracerebroventricular injections of 150 microg 5,7-dihydroxytryptamine (5,7-DHT), 2 microg 192 IgG-saporin, or a combination of both neurotoxins. All rats were tested for olfactory recognition (short-term memory) using a task based on spontaneous exploration of odor sources. Compared with animals undergoing sham operations, 5,7-DHT reduced the concentration of serotonin by 60-80% in the frontoparietal cortex, hippocampus, striatum and the olfactory bulbs. After 192 IgG-saporin treatment, acetylcholine concentrations were reduced by approximately 40% in all these structures, except the striatum. Neither lesion induced a significant deficit in olfactory recognition. These data suggest that combined lesions of cholinergic and serotonergic neurons in the rat brain do not alter olfactory perception or olfactory short-term memory.
authors.affiliation: LN2C, UMR 7521 Université Louis Pasteur/CNRS, Strasbourg, France.
authors.forename: S
authors.initials: S
authors.lastname: Wirth
authors.forename: O
authors.initials: O
authors.lastname: Lehmann
authors.forename: F
authors.initials: F
authors.lastname: Bertrand
authors.forename: C
authors.initials: C
authors.lastname: Lazarus
authors.forename: H
authors.initials: H
authors.lastname: Jeltsch
authors.forename: J C
authors.initials: JC
authors.lastname: Cassel
mesh_terms: D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism*; D000704:Analysis of Variance; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001070:Appetitive Behavior / Q000187:drug effects; D018678:Cholinergic Agents / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism; D000922:Immunotoxins / Q000494:pharmacology; D007276:Injections, Intraventricular; D008570:Memory, Short-Term / Q000187:drug effects / Q000502:physiology*; D009699:N-Glycosyl Hydrolases; D009638:Norepinephrine / Q000378:metabolism; D009830:Olfactory Bulb / Q000378:metabolism; D010296:Parietal Lobe / Q000378:metabolism; D051381:Rats; D020318:Rats, Long-Evans; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D012701:Serotonin / Q000378:metabolism*; D018490:Serotonin Agents / Q000494:pharmacology; D012903:Smell / Q000502:physiology*
chemical_list: C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D054789:Ribosome Inactivating Proteins, Type 1; D018490:Serotonin Agents; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D009699:N-Glycosyl Hydrolases; D000076985:Saporins; D000109:Acetylcholine; D009638:Norepinephrine